Sandbox Reserved 972

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 36: Line 36:
IDE can bind many substrates to its exosite and must recognize them. In order to accomplish this task, IDE uses many tools.
IDE can bind many substrates to its exosite and must recognize them. In order to accomplish this task, IDE uses many tools.
First, the lenght of the substrate peptide is essential. The peptide must be long enough to touch both the exosite and the catalytic site. Second, the peptide must be short enough in order to enter the catalytic chamber. In the case of the bradykinin, the length is too small to touch the catalytic site when it binds the exosite.
First, the lenght of the substrate peptide is essential. The peptide must be long enough to touch both the exosite and the catalytic site. Second, the peptide must be short enough in order to enter the catalytic chamber. In the case of the bradykinin, the length is too small to touch the catalytic site when it binds the exosite.
-
Song et al<ref>10.1074/jbc.M308983200</ref> have shown that bradykinin is too small to bind both at the exosite and the catalytic side. They prooved that IDE binds 2 bradykinin at the same time : the first one interacts with the exosite and the second one touches the catalytic site. The bradykinin in the catalytic site is the one which is going to be cleaved by the enzyme.
+
Song et al<ref>doi:10.1074/jbc.M308983200</ref> have shown that bradykinin is too small to bind both at the exosite and the catalytic side. They prooved that IDE binds 2 bradykinin at the same time : the first one interacts with the exosite and the second one touches the catalytic site. The bradykinin in the catalytic site is the one which is going to be cleaved by the enzyme.
This can be a discriminate factor, because IDE binds <scene name='60/604491/Bradykinin/1'>2 bradykinins</scene> at the same time.
This can be a discriminate factor, because IDE binds <scene name='60/604491/Bradykinin/1'>2 bradykinins</scene> at the same time.

Revision as of 21:29, 9 January 2015

This Sandbox is Reserved from 15/11/2014, through 15/05/2015 for use in the course "Biomolecule" taught by Bruno Kieffer at the Strasbourg University. This reservation includes Sandbox Reserved 951 through Sandbox Reserved 975.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
  3. Song ES, Juliano MA, Juliano L, Hersh LB. Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development. J Biol Chem. 2003 Dec 12;278(50):49789-94. Epub 2003 Oct 2. PMID:14527953 doi:http://dx.doi.org/10.1074/jbc.M308983200
  4. Malito E, Ralat LA, Manolopoulou M, Tsay JL, Wadlington NL, Tang WJ. Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme. Biochemistry. 2008 Nov 6. PMID:18986166 doi:10.1021/bi801192h
Personal tools